Scribe Therapeutics, Inc. ($SCTX)
Aghazadeh Behzad โ Director
Shares
7,905
Price
$18.25
Total Value
$144,266.25
P&L
+0.6% (+$869.55)
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Aghazadeh Behzad |
|---|---|
| Title | Director |
| Transaction Date | Jul 28, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock, par value $0.0001 per share |
| Direct/Indirect | Indirect |
| Nature of Ownership | See footnotes |
| Filing Date | Jul 29, 2026 |
| Shares Purchased | 7,905 |
| Price per Share | $18.25 |
| Total Value | $144,266.25 |
| Shares Owned After | 3,088,888 |
| Derivative | No |
| Accession Number | 0000902664-26-003270 |
| Document | View SEC Filing |